Sharpen pricing, prioritize molecular diagnostics and genomics, and guide R&D and investment amid point-of-care and self-testing disruption.Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Clinical Medical ...
4don MSN
Motilal Oswal initiates coverage on Molbio Diagnostics stock with buy, sees 21% upside. Here's why
Motilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong growth potential from decentralised molecular diagnostics, ...
First CNSide payer agreement to include CNSide’s new CSF Molecular Profile tests alongside tumor cell enumerationExpands CNSide contracted payer ...
ABL Texcell Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and services supporting clinical ...
(Nasdaq: CNSY) (“Cerenome” or the “Company ”), today announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to health care professionals in the ...
Roche Diagnostics has provided two molecular testing instruments to the Institut National de Santé Publique (INSP), which is supporting the DRC's Ministry of Health-led Ebola response. Roche will ...
Cerenome's CNSide Diagnostics launched two CSF-based molecular profiling tests for CNS cancers, analyzing DNA and RNA.
Denials of clinical laboratory, molecular diagnostic, and genomics claims rose to 11.2% in 2025 from 8.0% the year before, a ...
Azenta Life Sciences has detailed its customisable PCR plates, sealing materials and sample tracking options, designed to ...
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
NDTV Profit on MSN
Molbio Diagnostics shares in focus as Motilal Oswal initiates coverage; check target price
Motilal Oswal believes Molbio's successful diversification beyond TB, stronger international adoption and improving cash conversion could support a re-rating, while dependence on government orders and ...
New automation platform brings open, AI-assisted automation to molecular microbiology and NGS workflows, with configurations from €50,000 to €90,000 WOIPPY, FRANCE, October 5, 2026 /EINPresswire.com/ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results